Are you a newly diagnosed Multiple Myeloma patient? First of all, I’m sorry for your diagnosis of MM. Second of all, while conventional oncology cannot cure your myeloma, they can prescribe a variety of very expensive therapies that can help you go in and out of remission. This is what is meant by MM being very “treatable.”
As a long-term survivor of multiple myeloma possibly cured by a quack therapy, I encourage you to learn about both integrative and alternative therapies. You may choose not to undergo any of these therapies but knowledge is power as they say.
As the study linked and excerpted below confirms, Multiple Myeloma is an expensive cancer. Even great health insurance won’t cover co-pays, deductibles, etc.
Please learn about the many nutritional supplements such as curcumin and resveritrol that have extensively researched to both enhance conventional chemotherapies such as Velcade as well as reduce the toxicity of chemotherapies such as Velcade.
Simply because an expensive therapy such as an autologous stem cell transplant is recommended by your oncologist doesn’t mean that you have to do this therapy right away.
My point above is that you can save thousands of dollars by taking integrative therapies with conventional chemotherapies and you can postpone standard-of-care therapies.
If you would like specifics about any of the above, scroll down the page, post a question and I will reply ASAP.
Survivor, Creator, Director PeopleBeatingCancer
“Financial toxicity is increasingly affecting patient quality of life and medication adherence in patients with cancer. Due to the use of novel therapies and the need for extended treatment duration, patients with multiple myeloma are more vulnerable to it.1…
Patient-reported financial toxicity was common in an insured population with multiple myeloma, according to a study published online ahead of print in The Lancet Haematology…
Eligible patients were given a paper survey to complete on arrival for routine follow-up visits, and were asked to finish it before or after the visit. Insurance and treatment data were gathered from the patients’ electronic health records…
Results showed that:
- 59% of patients reported that treatment costs were higher than expected,
- 70% of patients had at least minor financial burden,
- 36% applied for financial assistance, and
- 21% of patients borrowed money to pay for medications.
Researchers concluded that additional attention should be paid to rising treatment costs and cost sharing is needed to address the increasing financial toxicity affecting patients with cancer.”